Skip to main content
Equibles

Swiss National Bank

Bank

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1582202 ZURICH, V8
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,759,595
-$655,154 QoQ
Shares Held
59,733
-5.1% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 256 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. TARS ranks #73 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in TARS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,759,595 59,733
2026-03-31 $4,414,749 62,933
2025-12-31 $5,112,014 62,433
2025-09-30 $3,633,134 61,133
2025-06-30 $2,573,721 63,533
2025-03-31 $2,852,730 55,533
2024-12-31 $2,897,678 52,333
2024-09-30 $1,701,498 51,733
2024-06-30 $1,286,510 47,333
2024-03-31 $1,542,439 42,433
2023-12-31 $847,118 41,833
2023-09-30 $878,424 49,433
2023-06-30 $631,239 34,933
2023-03-31 $470,532 37,433
2022-12-31 $613,271 41,833